MF
REGN icon

Manchester Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Manchester Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$7K – 515
2021
Q1 		$7K Hold
15
– – ﹤0.01% 493
2020
Q4 		$7K Hold
15
– – ﹤0.01% 418
2020
Q3 		$8K Hold
15
– – 0.01% 340
2020
Q2 		$9K Hold
15
– – 0.01% 319
2020
Q1 		$7K Buy
+15
New +$6.19K 0.01% 319

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Manchester Financial's REGN Position: Q2 2021 in Review

Manchester Financial sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 15 shares — an estimated $7K sold.

Manchester Financial first reported a position in REGN in Q1 2020 and held it in 5 quarters. The position peaked at $9K in Q2 2020. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • Manchester Financial reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 15 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $7K.
  • Manchester Financial first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Manchester Financial's Regeneron Pharmaceuticals position peaked at $9K in Q2 2020.
  • 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.